- Home
- GILD vs PLTR Comparison
GILD vs PLTR Comparison
Compare GILD & PLTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- PLTR
- Stock Information
- Founded
- GILD 1987
- PLTR 2003
- Country
- GILD United States
- PLTR United States
- Employees
- GILD N/A
- PLTR N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- PLTR Retail: Computer Software & Peripheral Equipment
- Sector
- GILD Health Care
- PLTR Technology
- Exchange
- GILD Nasdaq
- PLTR Nasdaq
- Market Cap
- GILD 113.0B
- PLTR 92.7B
- IPO Year
- GILD 1992
- PLTR 2020
- Fundamental
- Price
- GILD $93.94
- PLTR $82.24
- Analyst Decision
- GILD Buy
- PLTR Hold
- Analyst Count
- GILD 26
- PLTR 16
- Target Price
- GILD $96.71
- PLTR $37.64
- AVG Volume (30 Days)
- GILD 7.2M
- PLTR 93.6M
- Earning Date
- GILD 02-11-2025
- PLTR 02-03-2025
- Dividend Yield
- GILD 3.28%
- PLTR N/A
- EPS Growth
- GILD N/A
- PLTR 190.66
- EPS
- GILD 0.10
- PLTR 0.20
- Revenue
- GILD $28,299,000,000.00
- PLTR $2,646,338,000.00
- Revenue This Year
- GILD $6.50
- PLTR $28.76
- Revenue Next Year
- GILD $0.36
- PLTR $24.26
- P/E Ratio
- GILD $929.26
- PLTR $393.78
- Revenue Growth
- GILD 3.31
- PLTR 24.52
- 52 Week Low
- GILD $62.07
- PLTR $15.66
- 52 Week High
- GILD $98.90
- PLTR $84.80
- Technical
- Relative Strength Index (RSI)
- GILD 57.65
- PLTR 71.05
- Support Level
- GILD $90.27
- PLTR $71.50
- Resistance Level
- GILD $94.05
- PLTR $84.80
- Average True Range (ATR)
- GILD 1.99
- PLTR 5.13
- MACD
- GILD 0.07
- PLTR 0.19
- Stochastic Oscillator
- GILD 82.30
- PLTR 81.94
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About PLTR Palantir Technologies Inc.
Palantir is an analytical software company that focuses on leveraging data to create efficiencies in its clients' organizations. The firm serves commercial and government clients via its Foundry and Gotham platforms, respectively. The Denver-based company was founded in 2003 and went public in 2020.